Iranian Journal of Radiology

Published by: Kowsar

Immunohistochemical Subtypes of Breast Cancer: Correlation with Clinicopathological and Radiological Factors

Yu-Mee Sohn 1 , * , Kyunghwa Han 2 and Mirinae Seo 1
Authors Information
1 Department of Radiology, Kyung Hee University Hospital, College of Medicine, Kyung Hee University, Seoul, South Korea
2 Department of Radiology, Yonsei Biomedical Research Institute, Research Institute of Radiological Science, Seoul, South Korea
Article information
  • Iranian Journal of Radiology: October 01, 2016, 13 (4); e31386
  • Published Online: July 4, 2016
  • Article Type: Research Article
  • Received: July 10, 2015
  • Revised: November 17, 2015
  • Accepted: February 15, 2016
  • DOI: 10.5812/iranjradiol.31386

To Cite: Sohn Y, Han K, Seo M. Immunohistochemical Subtypes of Breast Cancer: Correlation with Clinicopathological and Radiological Factors, Iran J Radiol. 2016 ; 13(4):e31386. doi: 10.5812/iranjradiol.31386.

Abstract
Copyright © 2016, Tehran University of Medical Sciences and Iranian Society of Radiology. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Footnotes
References
  • 1. de Ronde JJ, Hannemann J, Halfwerk H, Mulder L, Straver ME, Vrancken Peeters MJ, et al. Concordance of clinical and molecular breast cancer subtyping in the context of preoperative chemotherapy response. Breast Cancer Res Treat. 2010; 119(1): 119-26[DOI][PubMed]
  • 2. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001; 98(19): 10869-74[DOI][PubMed]
  • 3. Yamamoto Y, Iwase H. Clinicopathological features and treatment strategy for triple-negative breast cancer. Int J Clin Oncol. 2010; 15(4): 341-51[DOI][PubMed]
  • 4. Goldhirsch A, Wood WC, Coates AS, Gelber RD, Thurlimann B, Senn HJ, et al. Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol. 2011; 22(8): 1736-47[DOI][PubMed]
  • 5. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature. 2000; 406(6797): 747-52[DOI][PubMed]
  • 6. Montagna E, Bagnardi V, Rotmensz N, Viale G, Cancello G, Mazza M, et al. Immunohistochemically defined subtypes and outcome in occult breast carcinoma with axillary presentation. Breast Cancer Res Treat. 2011; 129(3): 867-75[DOI][PubMed]
  • 7. Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006; 295(21): 2492-502[DOI][PubMed]
  • 8. Bae MS, Moon WK, Chang JM, Cho N, Park SY, Won JK, et al. Mammographic features of calcifications in DCIS: correlation with oestrogen receptor and human epidermal growth factor receptor 2 status. Eur Radiol. 2013; 23(8): 2072-8[DOI][PubMed]
  • 9. Ko ES, Lee BH, Kim HA, Noh WC, Kim MS, Lee SA. Triple-negative breast cancer: correlation between imaging and pathological findings. Eur Radiol. 2010; 20(5): 1111-7[DOI][PubMed]
  • 10. Kojima Y, Tsunoda H. Mammography and ultrasound features of triple-negative breast cancer. Breast Cancer. 2011; 18(3): 146-51[DOI][PubMed]
  • 11. Kojima Y, Tsunoda H, Honda S, Kikuchi M, Kawauchi N, Yoshida A, et al. Radiographic features for triple negative ductal carcinoma in situ of the breast. Breast Cancer. 2011; 18(3): 213-20[DOI][PubMed]
  • 12. Youk JH, Gweon HM, Son EJ, Kim JA, Jeong J. Shear-wave elastography of invasive breast cancer: correlation between quantitative mean elasticity value and immunohistochemical profile. Breast Cancer Res Treat. 2013; 138(1): 119-26[DOI][PubMed]
  • 13. Youk JH, Son EJ, Chung J, Kim JA, Kim EK. Triple-negative invasive breast cancer on dynamic contrast-enhanced and diffusion-weighted MR imaging: comparison with other breast cancer subtypes. Eur Radiol. 2012; 22(8): 1724-34
  • 14. Breast imaging reporting and data system(BI-RADS) mammography. 2013;
  • 15. American College of Radiology . Breast imaging reporting and data system(BI-RADS) ultrasound. 2013;
  • 16. Edge SB, Byrd DR CCC. AJCC cancer staging manual. 2010;
  • 17. Wolff AC, Hammond ME, Schwartz JN,, Hagerty KL, Allred DC, Cote RJ. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol. 2007; 25(1): 118-45
  • 18. Bloom HJ, Richardson WW. Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer. 1957; 11(3): 359-77[PubMed]
  • 19. Bae MS, Park SY, Song SE, Kim WH, Lee SH, Han W. Heterogeneity of triple-negative breast cancer: mammographic, US, and MR imaging features according to androgen receptor expression. Eur Radiol. 2014;
  • 20. Bae MS, Seo M, Kim KG, Park IA, Moon WK. Quantitative MRI morphology of invasive breast cancer: correlation with immunohistochemical biomarkers and subtypes. Acta Radiol. 2015; 56(3): 269-75[DOI][PubMed]
  • 21. Kim SH, Seo BK, Lee J, Kim SJ, Cho KR, Lee KY, et al. Correlation of ultrasound findings with histology, tumor grade, and biological markers in breast cancer. Acta Oncol. 2008; 47(8): 1531-8[DOI][PubMed]
  • 22. Seo BK, Pisano ED, Kuzimak CM, Koomen M, Pavic D, Lee Y, et al. Correlation of HER-2/neu overexpression with mammography and age distribution in primary breast carcinomas. Acad Radiol. 2006; 13(10): 1211-8[DOI][PubMed]
  • 23. Yang WT, Dryden M, Broglio K, Gilcrease M, Dawood S, Dempsey PJ, et al. Mammographic features of triple receptor-negative primary breast cancers in young premenopausal women. Breast Cancer Res Treat. 2008; 111(3): 405-10[DOI][PubMed]
  • 24. Dogan BE, Gonzalez-Angulo AM, Gilcrease M, Dryden MJ, Yang WT. Multimodality imaging of triple receptor-negative tumors with mammography, ultrasound, and MRI. AJR Am J Roentgenol. 2010; 194(4): 1160-6[DOI][PubMed]
  • 25. Choi YJ, Seong MH, Choi SH, Kook SH, Kwag HJ, Park YL. Ultrasound and clinicopathological characteristics of triple receptor-negative breast cancers. J Breast Cancer. 2011; 14(2): 119-23
  • 26. Caldarella A, Buzzoni C, Crocetti E, Bianchi S, Vezzosi V, Apicella P, et al. Invasive breast cancer: a significant correlation between histological types and molecular subgroups. J Cancer Res Clin Oncol. 2013; 139(4): 617-23[DOI][PubMed]
  • 27. Uematsu T, Kasami M, Yuen S. Triple-negative breast cancer: correlation between MR imaging and pathologic findings. Radiol. 2009; 250(3): 638-47
  • 28. Boisserie-Lacroix M, Mac Grogan G, Debled M, Ferron S, Asad-Syed M, Brouste V, et al. Radiological features of triple-negative breast cancers (73 cases). Diagn Interv Imaging. 2012; 93(3): 183-90[DOI][PubMed]
  • 29. Krizmanich-Conniff KM, Paramagul C, Patterson SK, Helvie MA, Roubidoux MA, Myles JD, et al. Triple receptor-negative breast cancer: imaging and clinical characteristics. AJR Am J Roentgenol. 2012; 199(2): 458-64[DOI][PubMed]
  • 30. Wang X, Chao L, Chen L, Ma G, Jin G, Hua M, et al. The mammographic correlations with Basal-like phenotype of invasive breast cancer. Acad Radiol. 2010; 17(3): 333-9[DOI][PubMed]
  • 31. Tamimi RM, Baer HJ, Marotti J, Galan M, Galaburda L, Fu Y, et al. Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer. Breast Cancer Res. 2008; 10(4)[DOI][PubMed]
  • 32. Wang Y, Ikeda DM, Narasimhan B, Longacre TA, Bleicher RJ, Pal S, et al. Estrogen receptor-negative invasive breast cancer: imaging features of tumors with and without human epidermal growth factor receptor type 2 overexpression. Radiology. 2008; 246(2): 367-75[DOI][PubMed]
  • 33. Leidy J, Khan A, Kandil D. Basal-like breast cancer: update on clinicopathologic, immunohistochemical, and molecular features. Arch Pathol Lab Med. 2014; 138(1): 37-43[DOI][PubMed]
  • 34. Koo HR, Park JS, Kang KW, Cho N, Chang JM, Bae MS, et al. 18F-FDG uptake in breast cancer correlates with immunohistochemically defined subtypes. Eur Radiol. 2014; 24(3): 610-8[DOI][PubMed]
  • 35. Wojcinski S, Soliman AA, Schmidt J, Makowski L, Degenhardt F, Hillemanns P. Sonographic features of triple-negative and non-triple-negative breast cancer. J Ultrasound Med. 2012; 31(10): 1531-41[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments